How to Buy Bristol Myers Squibb Co Stock
Bristol Myers Squibb Co
Bristol Myers Squibb Co is a general drug manufacturer company located in New York, United States, which is part of the Healthcare sector, and is traded under the ticker BMY on the NYSE exchange.
Bristol Myers Squibb Co stock last closed at $55.89, up 1.53% from the previous day, and has decreased 6.77% in one year. It has underperformed other stocks in the Drug Manufacturers - General industry by 0.33 percentage points. Bristol Myers Squibb Co stock is currently +31.44% from its 52-week low of $42.52, and -11.75% from its 52-week high of $63.33.
As of Feb 2, 2026, there are 2.04B BMY shares outstanding. The market value of BMY is $113.78B. In the last 24 hours, 9.42M BMY shares were traded.
How to Buy Bristol Myers Squibb Co Stock
Not sure how to invest in Bristol Myers Squibb Co stock? Here's how.
- Decide where to buy Bristol Myers Squibb Co stock: You need to pick a stock brokerage, but don't worry - we've tested dozens of online brokerages and apps to help you determine where to buy Bristol Myers Squibb Co stock.
- Create a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Put funds into your brokerage account: Select your payment method and add your details.
- Evaluate Bristol Myers Squibb Co stock: The Bristol Myers Squibb Co ticker symbol is BMY. Is Bristol Myers Squibb Co stock a good investment? Should you buy shares of BMY? How do BMY's underlying business fundamentals look? Do top analysts think Bristol Myers Squibb Co is a good buy? Why has BMY's stock price moved recently? (Hint: Our stock research tools can help you decide if BMY is a good stock to buy).
- Execute your BMY trade: Decide if you will purchase BMY shares at the current market price or use a limit order to purchase BMY shares at a specific price.
- Keep tabs on your investment in BMY: Create a watchlist to the latest updates on your position in Bristol Myers Squibb Co stock.
Step 1: Decide where to buy Bristol Myers Squibb Co stock
You will need an online brokerage account in order to access the NYSE market and buy BMY stock.
Our favorite brokerage: eToro
We believe that eToro is the best online stock brokerage. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you don't have the money to buy a full share, you can still invest in the stock.
- Access to global financial markets: From Technology to Healthcare, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
- Social investing: eToro boasts a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your share purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Create a brokerage account
Now that you've chosen your brokerage, you'll need to fill out some personal details so you are able to invest in BMY stock today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to open a new trading account.
- Submit your data by pressing the "Create Account" button. Get started with eToro today
Step 3: Put funds into your brokerage account
Now that you have filled out your info on the best stock investing app, your next step is to transfer the money for your investment:
Watch the video below for more details depositing money into your new brokerage account.
Step 4: Evaluate Bristol Myers Squibb Co stock
Once you have decided on the best place to buy Bristol Myers Squibb Co stock, it's crucial to evaluate their stock prior to investing, so you can understand the risk as well as the upside.
Bristol Myers Squibb Co Metrics
Bristol Myers Squibb Co Due Diligence Checks
WallStreetZen was built to help part-time investors perform more in-depth fundamental analysis quickly.
You can see all of the due diligence checks on BMY's stock page.
Is BMY stock overvalued?
Analysts use many financial metrics, analyses, models, and charts to gauge BMY's fair value.
Using relative valuations ratios:
- BMY may be undervalued based on its P/E ratio of 18.82x, relative to Drug Manufacturers - General industry P/E ratio of 45.01x
- BMY may be undervalued based on its P/B ratio of 6.13x, relative to Drug Manufacturers - General industry P/B ratio of 7.18x
- BMY may be undervalued based on its PEG ratio of 0.79x
You can access more valuation research on BMY's stock here.
A quick look at BMY Financials
Positive Financial Indicators:
- BMY earnings of $8.03B is not enough to cover its interest payments.
- BMY profit margin has gone up from -15.3% to 12.6% in the past year.
- BMY's operating cash flow of $16.62B allows it to safely service it's debt of $48.98B.
- There are more short-term assets than short-term liabilities on the BMY balance sheet.
Negative Financial Indicators:
- Total BMY debt is higher than 5 years ago, relative to shareholder equity.
- BMY has a relatively high debt to equity ratio of 4.22.
- There are more long-term liabilities than short-term assets on the BMY balance sheet.
Is BMY stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 10 Equities analysts who monitor BMY, the consensus analyst rating on BMY is a Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they financial advice.
Latest BMY Analyst Forecasts
Tim Anderson, a top 19% analyst from Bank of America upgrades BMY to a strong buy rating and raises their BMY price target from $52.00 to $61.00, on Dec 15, 2025.
Bank of America's Tim Anderson upgraded their rating on Bristol Myers Squibb Co (NYSE: BMY) from Hold to Strong Buy on 2025/12/15. The analyst also raised their price target by 17.3% from $52 to $61.
Citing the strength of Bristol Myers Squibb's R&D pipeline, Anderson hiked their price target.
The analyst said 4 to 6 programs should deliver key de-risking catalysts in the near future.
Anderson called the current weakness in the stock price a buying opportunity because conservative trough EPS estimate give the share price a floor.
Ahead of "a catalyst-rich 2026," the analyst pointed out that "good pharma pipeline stories can work once investors have visibility on the next product cycle."
Anderson said several scenarios are visible that would put Bristol Myers Squibb in a position to resume growth in 2029 and beyond.
Terence Flynn, a top 5% analyst from Morgan Stanley maintains BMY with a strong sell rating and raises their BMY price target from $36.00 to $37.00, on Dec 12, 2025.
Seamus Fernandez, a top 2% analyst from Guggenheim upgrades BMY to a strong buy rating and announces their BMY price target of $62.00, on Dec 12, 2025.
Mohit Bansal, a top 14% analyst from Wells Fargo maintains BMY with a hold rating and raises their BMY price target from $53.00 to $55.00, on Dec 10, 2025.
Asad Haider, a top 38% analyst from Goldman Sachs maintains BMY with a hold rating and raises their BMY price target from $51.00 to $57.00, on Dec 2, 2025.
You can dig deeper into what analysts are projecting on the Bristol Myers Squibb Co stock forecast page.
BMY Momentum
BMY Revenue
Last year, BMY earnings were $6.04B. Over the last 3 year, BMY's earnings have grown by -33.86% per year. This was slower than the Drug Manufacturers - General industry average of 11.76%.
Last year, BMY revenue was $48.03B. Over the past five year, BMY's revenue has grown by 4.05% per year. This was slower than the Drug Manufacturers - General industry average of 10.68%.
You can analyze BMY's earnings and revenue performance here.
Are BMY insiders buying or selling the stock?
In the last year, executives and large shareholders at BMY have sold more shares than they have bought.
Christopher S. Boerner, Chief Executive Officer of BMY, was the latest BMY insider to sell. They sold $57,034.66 worth of BMY stock on Nov 1, 2025.
Dig into more about who owns BMY shares here.
Can I rely on BMY as an income stream?
Bristol Myers Squibb Co pays a dividend of 3.35%, compared to the Drug Manufacturers - General industry's average dividend yield of 2.72%. If you owned $1,000 worth of BMY stock, you would have received $33.46 in the past 12 months.
Bristol Myers Squibb Co dividend payments have consistently grown over the past decade and have remained stable.
Dig into more analysis about Bristol Myers Squibb Co dividend yield and history here.
What others are saying about BMY
One of the major reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to learn what other traders have to say.
Step 5: Execute your BMY trade
You have two main options:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are mostly the easiest way to buy. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to make sure you're buying or selling at a given dollar amount limit, place a limit order.
Hit the Open Trade button and your broker will execute your order.
If you want additional info about investing in stocks on eToro, click the helpful video below:
Step 6: Keep tabs on your investment in BMY
Now that you own some BMY stock, you'll want to stay up-to-date on your company.
Create a watchlist to track the latest developments regarding your BMY stock.
BMY Feed
How to Buy Stock in Bristol Myers Squibb Co
To summarize, here are the 6 steps you need to take to buy Bristol Myers Squibb Co stock right now:
- Decide where to buy Bristol Myers Squibb Co stock
- Create a brokerage account
- Put funds into your brokerage account
- Evaluate Bristol Myers Squibb Co stock
- Execute your BMY trade
- Keep tabs on your investment in BMY
If you need a brokerage, eToro is our favorite option.
Get Started with eToro TodayIf you would like to monitor your investment in Bristol Myers Squibb Co, create a watchlist today.
More Articles You Might Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.